Workflow
Governor Pritzker Announces NANO Nuclear Energy to Establish Operations in Illinois
Globenewswire· 2025-10-07 13:30
NANO Nuclear Energy Inc. Governor Pritzker Announces NANO Nuclear Energy to Establish Operations in Illinois. NANO Nuclear Energy to receive REV Illinois incentive award of $6.8M New York, N.Y., Oct. 07, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that the Company, alongside Governor JB Pritzker and the Illinois Department of Commer ...
TopBuild to Release Third Quarter 2025 Results on Tuesday, November 4
Globenewswire· 2025-10-07 13:29
Conference Call and Webcast at 9:00 A.M. EasternDAYTONA BEACH, Fla., Oct. 07, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, announced it will release its third quarter 2025 results prior to 7:00 a.m. Eastern time on Tuesday, November 4. The Company will host a conference call at 9:00 a.m. that same day to ...
BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”
Globenewswire· 2025-10-07 13:25
MELVILLE, N.Y., Oct. 07, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today is pleased to announce that its CEO, Lance Alstodt, participated in an interview with “The Big Biz Show,” an Emmy Award-winning nationally syndicated TV and radio show. During the interview, Mr. Alstodt discussed BioRestorative’s recent achievements of key clinical and regulatory ...
POET Technologies Announces Closing of US$75 Million Investment to Accelerate Growth in AI Connectivity Solutions
Globenewswire· 2025-10-07 13:23
TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Corporation") (NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announced that it has closed a non-brokered financing with a single institutional investor. The Corporation issued and sold 13,636,364 common shares of the Corporation (the “common shares”) and one commo ...
Jet.AI Announces Successful Closing of AI Infrastructure Acquisition Corp., Adding Approximately $20 Million in Book Equity from Its Ownership Stake
Globenewswire· 2025-10-07 13:15
LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Jet.AI (the "Company") (Nasdaq: JTAI), a provider of high-performance GPU infrastructure and AI cloud services, announced that on October 3, 2025, AI Infrastructure Acquisition Corp. (NYSE: AIIAU), a special purpose acquisition company (SPAC), has successfully closed its initial public offering of 12,000,000 units at an offering price of $10.00 per unit. The offering was significantly oversubscribed and upsized from an initial 10,000,000 units because of strong d ...
24/7 Market News- Kraig Labs Unlocks Spider Silk at Scale, Solving a Centuries-Old Problem of Nature’s Strongest Fiber
Globenewswire· 2025-10-07 13:15
DENVER, Oct. 07, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, achieved a milestone in biotechnology: the successful mass production of spider silk using silkworms, solving a challenge that has eluded scientists and engineers for decades. For years, researchers have ...
AiRWA Inc. Announces Receipt of $30 Million of Solana Tokens into AiRWA Exchange, as well as Successful Test Runs Settling Trades of Tokenized U.S. Equities
Globenewswire· 2025-10-07 13:15
公司战略与定位 - 公司获得约3000万美元的Solana代币投资,以加强其交易所的财务基础,并推动将Solana整合为核心交易对资产[1] - 公司专注于服务加密货币爱好者,提供可像其他数字资产一样交易、数秒内完成结算的美国股票代币化交易平台[3] - 公司旨在创建一个创新平台,将区块链技术的效率速度与传统美国股票市场相结合,为加密用户提供便捷的美国股票代币化交易渠道[5] 业务进展与里程碑 - 公司交易所已完成美国股票代币化交易的测试运行,使用户能够以类似加密货币的简便和速度进行交易[2] - 交易所将首先向其合资伙伴JuCoin生态系统的大约400万用户推出该服务及主要加密货币交易能力,从而在启动首日即获得显著规模[4] 市场定位与竞争优势 - 公司通过整合Solana和代币化股票,旨在快速演变的数字资产市场中进一步区分其交易所,为机构和零售交易者提供无与伦比的灵活性和速度[5] - 公司通过其控股子公司拥有先进专利和专有技术,并授权给全球合作伙伴,同时活跃于Web3领域,专注于现实世界资产的代币化,特别是美国股票的代币化[6]
Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs
Globenewswire· 2025-10-07 13:15
Recent Issuance of U.S. Patents Covering ImmCelz™ — Supercharged Regulatory T Cell Programs in Heart Failure and Type 1 Diabetes Reinforce Creative Medical’s Similar Research FocusPHOENIX, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today congratulated Mary E. Brunkow, Ph.D., Fred Ramsdell, Ph.D., and Shimon Sakaguchi, M.D., Ph.D. on being award ...
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs
Globenewswire· 2025-10-07 13:05
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencingMENLO PARK, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions. Under the new agreement, PacBio will distribute seq ...
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care
Globenewswire· 2025-10-07 13:02
DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPharmaceuticals is expected to diversify and accelerate MannKind’s double-digit revenue growth, driven by FUROSCIX® (furosemide injection), an innovative therapy for edema due to chronic heart failure and chronic kidney disease. The transaction will strengthen MannKind’s commercial and medical ca ...